Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Patrys Ltd

PAB
Current price
0.006 AUD -0.000000000059 AUD (0.00%)
Last closed 0.007 AUD
ISIN AU000000PAB9
Sector Healthcare
Industry Biotechnology
Exchange Australian Securities Exchange
Capitalization 14 252 368 AUD
Yield for 12 month -14.29 %
1Y
3Y
5Y
10Y
15Y
PAB
21.11.2021 - 28.11.2021

Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. The company dvelops Deoxymab 3E10 also called PAT-DX1 for treating primary and secondary brain cancers, and metastases that are associated with NETosis, or in combination with DNA damaging agents such as radiation and many chemotherapy drugs. In addition, it develops PAT-DX3, a full-sized antibody that has DNA-targeting properties of PAT-DX1, but different pharmaceutic properties, such as tissue distribution, pharmacokinetic profile, etc. Further, it is involved in DNA targeting, blood-brain barrier, Inhibit NETosis human therapeutic applications. Patrys Limited was incorporated in 2006 and is based in Melbourne, Australia. Address: 96-100 Albert Road, Melbourne, VIC, Australia, 3205

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

0.18 AUD

P/E ratio

Dividend Yield

Current Year

Last Year

+2 824 581 AUD

Current Quarter

Last Quarter

+663 019 AUD

Current Year

-46 547 AUD

Last Year

+2 778 046 AUD

Current Quarter

Last Quarter

+663 019 AUD

Key Figures PAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -3 458 692 AUD
Operating Margin TTM -219 %
PE Ratio
Return On Assets TTM -37.86 %
PEG Ratio
Return On Equity TTM -68.67 %
Wall Street Target Price 0.18 AUD
Revenue TTM 1 380 805 AUD
Book Value 0.002 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -29.4 %
Dividend Yield
Gross Profit TTM 2 824 582 AUD
Earnings per share
Diluted Eps TTM
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -253.86 %

Dividend Analytics PAB

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History PAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:1
Payout Ratio
Last Split Date 01.07.2009
Dividend Date

Stock Valuation PAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1358.7841
Price Sales TTM 10.3218
Enterprise Value EBITDA -3.8529
Price Book MRQ 4.1468

Financials PAB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PAB

For 52 weeks

0.005 AUD 0.011 AUD
50 Day MA 0.0065 AUD
Shares Short Prior Month
200 Day MA 0.0078 AUD
Short Ratio
Shares Short
Short Percent